In this commentary, Kate Peng discusses the current thinking on quantification of protein therapeutic pharmacokinetics and protein biomarkers in clinical studies.
In this interview Ian Moore, Global Technical Marketing Manager at Sciex (Toronto, Canada), gives his insight into the innovations and challenges he has faced whilst working in drug development.
View some of the poster presentations delivered at this years 11th WRIB conference.
This infographic presents key results from the bioanalysis of biopharmaceuticals and biomarkers survey.
In this commentary, the authors discuss the benefits and challenges of using ‘ready-to-use’ cells from a frozen bank of uniform, tested, aliquots.
In this podcast, we speak with Erik Burns and Jim De Muth to find out more about the upcoming 18th…
In this conversation with Chris Beaver from InVentiv Health (MA, USA), Chris shares his experience of transitioning from academia into…